title: Sclerodermiform porphyria cutanea tarda after torasemide.
authors.affiliation: Medical University Graz, Department of Dermatology, Auenbruggerplatz 8, 8036 Graz, Austria.
authors.forename: Bettina
authors.initials: B
authors.lastname: Kranzelbinder
authors.affiliation: Medical University Graz, Department of Dermatology, Auenbruggerplatz 8, 8036 Graz, Austria.
authors.forename: Michaela
authors.initials: M
authors.lastname: Wiednig
authors.affiliation: Medical University Graz, Department of Dermatology, Auenbruggerplatz 8, 8036 Graz, Austria.
authors.forename: Laila
authors.initials: L
authors.lastname: El-Shabrawi-Caelen
authors.affiliation: Medical University Graz, Department of Dermatology, Auenbruggerplatz 8, 8036 Graz, Austria.
authors.forename: Werner
authors.initials: W
authors.lastname: Aberer
authors.affiliation: Medical University Graz, Department of Dermatology, Auenbruggerplatz 8, 8036 Graz, Austria.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Aberer
mesh_terms: D000368:Aged; D001707:Biopsy, Needle; D003131:Combined Modality Therapy; D018450:Disease Progression; D017809:Fatal Outcome; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D017119:Porphyria Cutanea Tarda / Q000139:chemically induced* / Q000473:pathology* / Q000628:therapy; D018570:Risk Assessment; D012594:Scleroderma, Localized / Q000139:chemically induced / Q000473:pathology / Q000628:therapy; D012720:Severity of Illness Index; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D000077786:Torsemide
chemical_list: D013449:Sulfonamides; D000077786:Torsemide